Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Lipoprotein(a) levels can guide CV risk assessment and treatment

Key clinical point: High levels of lipoprotein(a) are an independent risk factor for atherosclerotic cardiovascular disease.

Major finding: Serum Lp(a) levels can be used to decide patient risk and treatment options for cardiovascular disease.

Study details: Scientific statement from the National Lipid Association.

Disclosures: Five authors disclosed honorarium or advisory board positions with the pharmaceutical sector. No other conflicts of interest were declared.

Citation:

Wilson D et al. J Clin Lipidol. 2019 May 17. doi: 10.1016/j.jacl.2019.04.010.